Genome Editing Market : Emerging Market Trends, Top Growing Segments & Future Developments
2022-07-15 05:40:29 UTC | Healthcare & Pharmaceuticals
Developments in the genome editing market
have led to significant improvements in the genome editing capabilities
that have enabled the modification of gene sequences of interest in a
wide variety of cell types and model organisms. Genome engineering,
earlier used by large research organizations, such as academic and
government research centers, has now become a potentially transformative
diagnostic tool, especially for oncology studies.
from academics to clinical and diagnostic laboratories is primarily
driven by rapid improvements in gene editing technologies.According
to research report the global genome editing market size is expected to
grow at a CAGR of 18.2% during the forecast period. The global genome
engineering market is projected to reach USD 11.7 billion by 2026 from
USD 5.1 billion in 2021.
Based on technology, the genome
editing market is segmented into CRISPR, TALEN, ZFN, antisense, and
other technologies. The CRISPR segment accounted for the largest share
of 63.1% of the genetic engineering market in 2020.
The ease of
use associated with CRISPR technology gives it a significant advantage
over ZFN and TALEN, especially in generating a large set of vectors to
target numerous sites or even genome-wide libraries.
potential advantage of CRISPR is its ability to use multiple guide RNA
parallelly to target multiple sites simultaneously in the same cell.
This makes it easier to mutate multiple genes at once or engineer
precise deletions in a genomic region and has attributed to the growth
of this technology.Download PDF Brochure
on product & service, the genome editing market is segmented into
reagents & consumables, software & systems, and services. The
reagents & consumables segment accounted for the largest share of
58.8% in 2020, mainly due to the repetitive purchase of reagents and
consumables as well as the rising demand for and multiple uses of
editing and sequencing.
Based on application, the genome
engineering market is segmented into cell line engineering, genetic
engineering, diagnostic applications, drug discovery & development,
and other applications. The cell line engineering segment accounted for
the largest share of 32.0% of the market in 2020.
availability of funds for the purchase of new stem cell lines, the
development of advanced genomic methods for stem cell analysis, and the
rising number of approvals for the clinical trials of stem cell
therapies are some of the factors expected to further support the growth
of the market segment.
The Gene Editing Market is divided into
five major regions—North America, Europe, Asia Pacific, Latin America
(LATAM), and the Middle East and Africa (MEA). North America accounted
for the largest share of this market, followed by Europe in 2020.
key factors driving the growth of the market in North America include
the development of gene therapy, increased use of GM crops, and a rise
in the availability of research grants and funding in the US. The market
in Canada is expected to witness growth in the coming years owing to
various government initiatives and the intensification of genomics
R&D (through GAPP) in the country.Browse 147 market data Tables and 48 Figures spread through 208 Pages and in-depth TOC on "genome editing market"https://www.marketsandmarkets.com/Market-Reports/genome-editing-engineering-market-231037000.htmlContact:Mr. Aashish MehraMarketsandMarkets™ INC.
630 Dundee Road
Northbrook, IL 60062